Is there a place for a molecular diagnostic test for pelvic inflammatory disease in primary care? An exploratory qualitative study

<h4>Introduction</h4> There is currently no test for pelvic inflammatory disease (PID) that is non-invasive and sufficiently sensitive and specific. Clinicians must therefore diagnose PID clinically, ruling out medical emergencies and conducting pelvic examinations where possible. While...

Full description

Bibliographic Details
Main Authors: Helen Bittleston, Jane S. Hocking, Jane L. Goller, Jacqueline Coombe, Deborah Bateson, Sally Sweeney, Kirsteen Fleming, Wilhelmina M. Huston
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484633/?tool=EBI
_version_ 1828733580910526464
author Helen Bittleston
Jane S. Hocking
Jane L. Goller
Jacqueline Coombe
Deborah Bateson
Sally Sweeney
Kirsteen Fleming
Wilhelmina M. Huston
author_facet Helen Bittleston
Jane S. Hocking
Jane L. Goller
Jacqueline Coombe
Deborah Bateson
Sally Sweeney
Kirsteen Fleming
Wilhelmina M. Huston
author_sort Helen Bittleston
collection DOAJ
description <h4>Introduction</h4> There is currently no test for pelvic inflammatory disease (PID) that is non-invasive and sufficiently sensitive and specific. Clinicians must therefore diagnose PID clinically, ruling out medical emergencies and conducting pelvic examinations where possible. While guidelines state that clinicians should be prepared to over-diagnose PID, it remains an under-diagnosed condition, with severe reproductive health impacts when left untreated. This research is the first to consider the perspectives of end-users on the development of a diagnostic test for PID. <h4>Methods</h4> Semi-structured live video feed online (Zoom) interviews were conducted with 11 clinicians and nine women (aged 18–30 years) in Australia to understand how a diagnostic test might be used, and what characteristics a test would need for it to be acceptable to clinicians and young women. Participants were recruited via researcher and university student networks. Reflexive thematic analysis was used to identify key themes relating to the acceptability and characteristics of a diagnostic test for PID. <h4>Results</h4> Seven general practitioners, four clinicians working in sexual health clinics, and nine young women (aged 21–27 years) were interviewed. Clinicians were aged between 31–58 years and were predominantly female. Clinicians recognised that the development of an accurate test to diagnose PID would be valuable to themselves and other clinicians, particularly those who lack experience diagnosing PID, and those working in certain settings, including emergency departments. They discussed how they might use a test to enhance their clinical assessment but highlighted that it would not replace clinical judgement. Clinicians also considered how a test would impact the patient experience and time to treatment, emphasising that it should be minimally invasive and have a quick turnaround time. Young women said a test would be acceptable if endorsed by a trustworthy clinician. <h4>Conclusions</h4> PID remains a challenging diagnosis. Development of a minimally invasive and sufficiently accurate diagnostic test would be acceptable to young women and benefit some clinicians, although no test would completely replace an experienced clinician’s judgement in making a PID diagnosis.
first_indexed 2024-04-12T22:32:14Z
format Article
id doaj.art-e6f6e556b5a24b60a2b6ee9d5cf9f850
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-12T22:32:14Z
publishDate 2022-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-e6f6e556b5a24b60a2b6ee9d5cf9f8502022-12-22T03:13:56ZengPublic Library of Science (PLoS)PLoS ONE1932-62032022-01-01179Is there a place for a molecular diagnostic test for pelvic inflammatory disease in primary care? An exploratory qualitative studyHelen BittlestonJane S. HockingJane L. GollerJacqueline CoombeDeborah BatesonSally SweeneyKirsteen FlemingWilhelmina M. Huston<h4>Introduction</h4> There is currently no test for pelvic inflammatory disease (PID) that is non-invasive and sufficiently sensitive and specific. Clinicians must therefore diagnose PID clinically, ruling out medical emergencies and conducting pelvic examinations where possible. While guidelines state that clinicians should be prepared to over-diagnose PID, it remains an under-diagnosed condition, with severe reproductive health impacts when left untreated. This research is the first to consider the perspectives of end-users on the development of a diagnostic test for PID. <h4>Methods</h4> Semi-structured live video feed online (Zoom) interviews were conducted with 11 clinicians and nine women (aged 18–30 years) in Australia to understand how a diagnostic test might be used, and what characteristics a test would need for it to be acceptable to clinicians and young women. Participants were recruited via researcher and university student networks. Reflexive thematic analysis was used to identify key themes relating to the acceptability and characteristics of a diagnostic test for PID. <h4>Results</h4> Seven general practitioners, four clinicians working in sexual health clinics, and nine young women (aged 21–27 years) were interviewed. Clinicians were aged between 31–58 years and were predominantly female. Clinicians recognised that the development of an accurate test to diagnose PID would be valuable to themselves and other clinicians, particularly those who lack experience diagnosing PID, and those working in certain settings, including emergency departments. They discussed how they might use a test to enhance their clinical assessment but highlighted that it would not replace clinical judgement. Clinicians also considered how a test would impact the patient experience and time to treatment, emphasising that it should be minimally invasive and have a quick turnaround time. Young women said a test would be acceptable if endorsed by a trustworthy clinician. <h4>Conclusions</h4> PID remains a challenging diagnosis. Development of a minimally invasive and sufficiently accurate diagnostic test would be acceptable to young women and benefit some clinicians, although no test would completely replace an experienced clinician’s judgement in making a PID diagnosis.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484633/?tool=EBI
spellingShingle Helen Bittleston
Jane S. Hocking
Jane L. Goller
Jacqueline Coombe
Deborah Bateson
Sally Sweeney
Kirsteen Fleming
Wilhelmina M. Huston
Is there a place for a molecular diagnostic test for pelvic inflammatory disease in primary care? An exploratory qualitative study
PLoS ONE
title Is there a place for a molecular diagnostic test for pelvic inflammatory disease in primary care? An exploratory qualitative study
title_full Is there a place for a molecular diagnostic test for pelvic inflammatory disease in primary care? An exploratory qualitative study
title_fullStr Is there a place for a molecular diagnostic test for pelvic inflammatory disease in primary care? An exploratory qualitative study
title_full_unstemmed Is there a place for a molecular diagnostic test for pelvic inflammatory disease in primary care? An exploratory qualitative study
title_short Is there a place for a molecular diagnostic test for pelvic inflammatory disease in primary care? An exploratory qualitative study
title_sort is there a place for a molecular diagnostic test for pelvic inflammatory disease in primary care an exploratory qualitative study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484633/?tool=EBI
work_keys_str_mv AT helenbittleston isthereaplaceforamoleculardiagnostictestforpelvicinflammatorydiseaseinprimarycareanexploratoryqualitativestudy
AT janeshocking isthereaplaceforamoleculardiagnostictestforpelvicinflammatorydiseaseinprimarycareanexploratoryqualitativestudy
AT janelgoller isthereaplaceforamoleculardiagnostictestforpelvicinflammatorydiseaseinprimarycareanexploratoryqualitativestudy
AT jacquelinecoombe isthereaplaceforamoleculardiagnostictestforpelvicinflammatorydiseaseinprimarycareanexploratoryqualitativestudy
AT deborahbateson isthereaplaceforamoleculardiagnostictestforpelvicinflammatorydiseaseinprimarycareanexploratoryqualitativestudy
AT sallysweeney isthereaplaceforamoleculardiagnostictestforpelvicinflammatorydiseaseinprimarycareanexploratoryqualitativestudy
AT kirsteenfleming isthereaplaceforamoleculardiagnostictestforpelvicinflammatorydiseaseinprimarycareanexploratoryqualitativestudy
AT wilhelminamhuston isthereaplaceforamoleculardiagnostictestforpelvicinflammatorydiseaseinprimarycareanexploratoryqualitativestudy